Livia S. Eberlin
Associate Professor, Department of Surgery, Baylor College of Medicine, USA
Predictions? I believe mass spectrometry is set to revolutionize medical practice and clinical decision making. I foresee that, in the next 5–10 years, medical professionals including pathologists, oncologists, and surgeons who currently do not have access to the power of mass spectrometry technology for molecular analysis will be using it in a very intuitive way to help define the best treatment options for their patients.
Controversial opinion? For many years, I’ve been passionate about ambient ionization mass spectrometry and direct mass spectrometry analysis and the value that these technologies have in medicine and clinical practice. Generally, I have perceived that the limitations of these techniques when compared with more traditional chromatography-based mass spectrometry approaches have led many to doubt or disagree with their potential in medical practice, but I think we are now at a stage where there is a more palpable excitement and belief that these technologies can truly make it to the clinic.
Mission? To bring direct mass spectrometry technologies to medicine and medical professionals to truly transform the ways doctors diagnose and treat their patients!
